Karyopharm Therapeutics (KPTI) Inventory (2019 - 2026)
Karyopharm Therapeutics' (KPTI) quarterly Inventory came in at $4.0 million in Q4 2025, down 14.79% YoY from $4.7 million in Q4 2024, and up 1.82% on a QoQ basis from $4.0 million in Q3 2025.
Karyopharm Therapeutics (KPTI) Inventory (2019 - 2026) Analysis & Trends
Karyopharm Therapeutics (KPTI) has 7 years of Inventory data on file, last reported at $4.0 million in Q4 2025.
- Quarterly Inventory fell 14.79% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (down 14.79% YoY) and the FY2025 annual result came in at $4.0 million, down 14.79% from the prior year.
- Inventory improved to $4.0 million in Q4 2025, from $4.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $5.0 million in Q2 2025 to a low of $2.8 million in Q1 2024.
- A 5-year average of $3.9 million and a median of $3.9 million in 2021 frame the typical range for Inventory.
- Annual changes were most pronounced in 2021 — Inventory surged 221.03% — and 2023, when it declined 27.96%.
- Tracing KPTI's Inventory over 5 years: stood at $4.1 million in 2021, then grew by 2.87% to $4.2 million in 2022, then slipped by 27.96% to $3.0 million in 2023, then surged by 55.73% to $4.7 million in 2024, then retreated by 14.79% to $4.0 million in 2025.
- The last three Inventory figures came in at $4.0 million (Q4 2025), $4.0 million (Q3 2025), and $5.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | - |
| 10 | Karyopharm Therapeutics | 56.00 Mn | 56.00 Mn | 32.35 Mn | 3.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.99 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 4.99 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 4.74 Mn |
| Sep 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 2.77 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 4.22 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.87 Mn |
| Dec 31, 2021 | 4.11 Mn |
| Sep 30, 2021 | 3.94 Mn |
| Jun 30, 2021 | 3.91 Mn |